Eupraxia Pharmaceuticals Inc. a clinical-stage biotechnology company specializing in precision local drug delivery, today announced

MAXONA Pharmaceuticals today announced the United States Patents and Trademark Office (USPTO) has issued

Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs

The American Pharmacists Association (APhA) has selected seven recipients of its 2025 Immunization Champion Awards, recognizing individuals

TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), is pleased to announce the appointment of Katarina Ageborg

BluMaiden Biosciences, an AI drug discovery company pioneering a proprietary reverse translation approach that enables target and natural product bases drug

Today, the U.S. Food and Drug Administration (FDA) approved Merilog (insulin aspart szij) as a biosimilar product to Novolog

Eupraxia Pharmaceuticals Inc. a clinical-stage biotechnology company, today announced that it has appointed Alex Rothwell

Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology

VIVOZON Pharmaceutical announced that its non-opioid analgesic, UNAFRA Inj., was approved(Active ingredient: Opiranserin HCl)